Track topics on Twitter Track topics that are important to you
Folcaps™ Omega-3 is a prenatal/postnatal multivitamin/mineral capsule with omega-3 fatty acids.
Each red soft gelatin capsule for oral administration contains:
INACTIVE INGREDIENTS: Gelatin, glycerin, yellow beeswax, silicon dioxide, purified water, soy lecithin, titanium dioxide, FD&C Red #40, ethyl vanillin, and corn oil.
|Essential Fatty Acids:|
| Omega-3 Fatty Acids
|Docohexaenoic Acid (DHA)||260 mg|
|Eicosapentaenoic Acid (EPA)||40 mg|
|Alpha-linolenic Acid (ALA)||30 mg|
|Linoleic Acid||30 mg|
|Vitamin C (as calcium ascorbate and calcium threonate)||25 mg|
|Vitamin D3 (cholecalciferol)||170 IU|
|Vitamin E (dl-alpha-tocopheryl acetate)||30 IU|
|Folic Acid, USP||1 mg|
|Vitamin B6 (pyridoxine hydrochloride)||25 mg|
|Calcium Iron (elemental)||150 mg|
|Carbonyl iron||20 mg|
|Ferrous Asparto Glycinate||7 mg|
Folcaps™ Omega-3 is intended to provide improved nutritional status before, during, and after pregnancy, through dietary supplementation of key vitamin/mineral and omega-3 fatty acids.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anti-coagulants and in those known to have inherited or acquired bleeding diathesis.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
Do not exceed recommended dosage. Folcaps™ Omega-3 should be used with caution in patients with known sensitivity or allergy to fish or soy.
Safety and effectiveness in pediatric patients have not been established.
Clinical studies on this product have not been performed to determine whether elderly subjects respond differently from younger subjects.
In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Usual dosage is one capsule daily, or as prescribed by a physician.
Folcaps™ Omega-3 prenatal/postnatal multivitamin/mineral capsules are red soft gelatin, packaged in bottles of 30 capsules.(NDC: 68308-269-30)
Store at controlled room temperature 15°-30° C (59°-86° F). [See USP controlled room temperature.]
THIS PRODUCT CONTAINS SOY.
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
NDC 68308-269-3030 Capsules
DESCRIPTION: Folcaps™ Omega-3 is a prenatal/postnatalmultivitamin/mineral capsule with omega-3 fatty acids.
INACTIVE INGREDIENTS: Gelatin, glycerin, yellow beeswax,silicon dioxide, purified water, soy lecithin, titanium dioxide,FD&C Red #40, ethyl vanillin, and corn oil.
Folcaps™ Care One
RE OB 90 + DHA
Mi-Omega NF Capsules
Animi-3 with Vitamin D
To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a spe...
Comparative bioavailability and pharmacodynamics effects of MAT9001 versus an active omega-3 medication comparator.
The primary objective of this study is to evaluate the efficacy of REMOGEN® OMEGA in reducing Dry Eye Syndrome (DES) symptoms.
The purpose of this study is to find an optimal dose of omega-3 that can be given to children who have completed cancer therapy. The future aim is to add omega-3 to conventional cancer tre...
An increase in intake of omega-3 fatty acids should increase the Omega-3 Index. Current evidence indicates that this may lead to a reduction in risk for sudden cardiac death and atheroscle...
Omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), such as α-linolenic and linoleic acids, are essential fatty acids in mammals, because they cannot be synthesized de novo. However, fat-1 trans...
Since fatty acid composition of uterus phospholipids is likely to influence embryo implantation, this study was conducted to investigate the effects of dietary omega-3 and -6 fatty acids on implantati...
Colorectal cancer is a common malignancy and one of the leading causes of cancer-related deaths. The metabolism of omega fatty acids has been implicated in tumour growth and metastasis.
Determine the efficacy and tolerability of omega-3 fatty acids versus soybean isoflavones in reducing the vasomotor symptoms (VMSs) frequency in postmenopausal women. A randomized, prospective, two-ar...
Recently, concerns have been raised with regard to the recommended doses of marine long-chain omega-3 polyunsaturated fatty acids (LC-omega-3 PUFAs) especially in relation to cancer risk and treatment...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...